Related Experiment Video
Updated: Dec 13, 2025

Procurement for a Vascularized and Reinnervated Abdominal Wall Allotransplantation
Published on: July 18, 2025
Body donation as a grateful gift for a long and active life with a Björk-Shiley valve
Kevin Rudolph1, Carlos Galvez2, Julie Chang2
1Institute for Anatomy and Cell Biology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Insights
A Björk-Shiley convexo-concave (BSCC) prosthetic aortic valve functioned for over 34 years, a remarkable longevity. Post-mortem analysis revealed no signs of failure, highlighting the potential for extended BSCC valve survival.
Area of Science:
- Cardiovascular Surgery
- Biomedical Engineering
- Geriatric Medicine
Background:
- The Björk-Shiley convexo-concave (BSCC) prosthetic aortic valve was implanted in a patient 34 years prior.
- Earlier BSCC valve designs are associated with a high mortality rate due to potential failure.
- Prosthetic valve longevity is a critical factor in patient outcomes and quality of life.
Observation:
- An 87-year-old male donated his body for anatomical study.
- The patient had a history of a BSCC prosthetic aortic valve implanted 34 years ago.
- He remained highly active, working as a firefighter, throughout his life.
Findings:
- Dissection revealed an enlarged heart but no significant thrombosis or fibrosis around the valve.
- No pathological signs indicative of valve failure were identified.
- The BSCC prosthetic aortic valve demonstrated exceptional longevity and biocompatibility in this case.
Implications:
- This case suggests that some BSCC valves may achieve exceptionally long functional lifespans.
- Understanding the factors contributing to such longevity could inform future prosthetic valve design.
- Long-term survival with older prosthetic valves is possible, challenging established mortality rates.
Abstract:
An 87-year-old patient donated his body to the Institute of Anatomy and Cell Biology in gratefulness for the longevity of a Björk-Shiley convexo-concave (BSCC) prosthetic aortic valve, implanted 34 years ago. The dissection of the enlarged heart showed no major signs of thrombosis, malignant fibrosis, or any other relevant issue that could potentially lead to valve failure as in other patients. Despite the reported high mortality rate of the earlier designs, especially of the BSCC valves, some patients survived for longer than expected. In more than 34 years after the BSCC valve implantation, the patient was a very active and lively man, working both as full-time and volunteer firefighter. The lifespan of this BSCC valve is among the longest reported.
More Related Videos
06:40A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Related Concept Videos
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...